Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells
Biomolecules · 10.07.2023 · 13 (7) · 1099
DOI: 10.3390/biom13071099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 10.07.2023. Verfasst von Thamir M Ismail und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Systems Biology, University of Liverpool, Liverpool L69 7ZB, UK. Hauptthemen laut MEDLINE: S100 Calcium-Binding Protein A4, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council, Cancer and Polio Research Fund, Wirral UK.
Abstract (Originalsprache)
Most patients who die of cancer do so from its metastasis to other organs. The calcium-binding protein S100A4 can induce cell migration/invasion and metastasis in experimental animals and is overexpressed in most human metastatic cancers. Here, we report that a novel inhibitor of S100A4 can specifically block its increase in cell migration in rat (IC50, 46 µM) and human (56 µM) triple negative breast cancer (TNBC) cells without affecting Western-blotted levels of S100A4. The moderately-weak S100A4-inhibitory compound, US-10113 has been chemically attached to thalidomide to stimulate the proteasomal machinery of a cell. This proteolysis targeting chimera (PROTAC) RGC specifically eliminates S100A4 in the rat (IC50, 8 nM) and human TNBC (IC50, 3.2 nM) cell lines with a near 20,000-fold increase in efficiency over US-10113 at inhibiting cell migration (IC50, 1.6 nM and 3.5 nM, respectively). Knockdown of S100A4 in human TNBC cells abolishes this effect. When PROTAC RGC is injected with mouse TNBC cells into syngeneic Balb/c mice, the incidence of experimental lung metastases or local primary tumour invasion and spontaneous lung metastasis is reduced in the 10–100 nM concentration range (Fisher’s Exact test, p ≤ 0.024). In conclusion, we have established proof of principle that destructive targeting of S100A4 provides the first realistic chemotherapeutic approach to selectively inhibiting metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Systems Biology, University of Liverpool, Liverpool L69 7ZB, UK.
- Department of Chemistry, University of Liverpool, Liverpool L69 7ZB, UK.
- Department of Clinical Infection, Microbiology and Immunity, University of Liverpool, Liverpool L69 7ZB, UK.
- Medical School, Southeast University, Nanjing 230032, China.
- Department of Gastroenterology, First Affiliated Hospital, Anhui Medical University, Hefei 210009, China.
ORCID-Profile: Roger Barraclough, Guozheng Wang, Weiping Yu, Gemma Nixon
Förderung
- Cancer Research UK
- Medical Research Council
- Cancer and Polio Research Fund, Wirral UK
- Medical Research Council UK
- Engineering and Physical Sciences Research Council UK
Zitieren
APA
Ismail, T. M., Crick, R. G., Du, M., Shivkumar, U., Carnell, A., Barraclough, R., Wang, G., Cheng, Z., Yu, W., Platt-Higgins, A., Nixon, G., & Rudland, P. S. (2023). Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells. Biomolecules, 13(7), 1099. https://doi.org/10.3390/biom13071099
Vancouver
Ismail TM, Crick RG, Du M, Shivkumar U, Carnell A, Barraclough R, et al. Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells. Biomolecules. 2023;13(7):1099. doi:10.3390/biom13071099
BibTeX
@article{Ismail2023,
author = {Ismail, Thamir M and Crick, Rachel G and Du, Min and Shivkumar, Uma and Carnell, Andrew and Barraclough, Roger and Wang, Guozheng and Cheng, Zhenxing and Yu, Weiping and Platt-Higgins, Angela and Nixon, Gemma and Rudland, Philip S},
title = {Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {7},
pages = {1099},
doi = {10.3390/biom13071099}
}
EUVIMED